Alaa M. Altahan
Hematology Oncology | Hematology | Oncology
270 International Circle
Building 3 1st Floor
San Jose, CA 95119
Building 3 1st Floor
San Jose, CA 95119
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Mutant PPM1D- and TP53-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy.
Journal: JCO precision oncology
Published: January 13, 2022
Severe Hemolysis in a COVID-19 Patient with Paroxysmal Nocturnal Hemoglobinuria.
Journal: Case reports in hematology
Published: December 19, 2020
Impact of margin status on survival after radical nephrectomy for renal cell carcinoma.
Journal: Journal of surgical oncology
Published: October 19, 2020
Association Between Pesticide Use and Incidence of Diffuse Large B-Cell Lymphoma.
Journal: Anticancer research
Published: June 28, 2020
CIN or not: An approach to the evaluation and management of chronic idiopathic neutrophilia.
Journal: Blood reviews
Published: February 17, 2020
Age-Related Chromosomal Aberrations in Patients with Diffuse Large B-Cell Lymphoma: An In Silico Approach.
Journal: World journal of oncology
Published: July 17, 2018
KDM5A Regulates a Translational Program that Controls p53 Protein Expression.
Journal: iScience
Published: January 23, 2018
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
Journal: Cancer research
Published: March 23, 2016
Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 25, 2015
The role of histone demethylase KDM4B in Myc signaling in neuroblastoma.
Journal: Journal of the National Cancer Institute
Published: May 01, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026